Ukkola Olavi, Ravussin Eric, Jacobson Peter, Sjöström Lars, Bouchard Claude
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808-4124, USA.
Metabolism. 2003 Jul;52(7):881-4. doi: 10.1016/s0026-0495(03)00074-x.
Adiponectin (also called AdipoQ, gelatin-binding protein 28, Acrp30) DNA sequence variants were determined in 96 unrelated female subjects with severe obesity (mean body mass index [BMI], 42.3 kg/m2) and in 96 non-obese female controls (mean BMI, 23.0 kg/m2) from the Swedish Obese Subjects (SOS) cohort. A single base substitution (T45G) at codon 15 of exon 2 resulting in no change in amino acid (Gly15Gly) was found in equal frequencies among obese and control subjects. However, this polymorphism was associated with serum cholesterol and waist circumference (P=.023 and.043, respectively) in the obese group. A IVS2 + G62T sequence variation was also identified, but had similar prevalence rates in obese and control subjects. Blood glucose was highest in the obese female subjects who were homozygotes for the G allele (GG) of the IVS2 + G62T polymorphism (N=56; P=.033) and all the diabetics (n=6) in this sample were in this group. IVS2 + G62T polymorphism was also associated with BMI (P=.014), diastolic blood pressure (P=.009), and sagittal diameter (P=.032). A missense point mutation at codon 111 (Tyr111His) was not associated with any obesity-related phenotypes. In conclusion, adiponectin DNA sequence variations might play a role in the complications of morbid obesity and should be further investigated.
在瑞典肥胖受试者(SOS)队列中,对96名患有严重肥胖症的非亲属女性受试者(平均体重指数[BMI]为42.3kg/m²)和96名非肥胖女性对照者(平均BMI为23.0kg/m²)测定了脂联素(也称为AdipoQ、明胶结合蛋白28、Acrp30)的DNA序列变异。在外显子2的第15密码子处发现了一个单碱基替换(T45G),其氨基酸无变化(Gly15Gly),在肥胖受试者和对照者中的出现频率相同。然而,这种多态性与肥胖组的血清胆固醇和腰围相关(分别为P = 0.023和0.043)。还鉴定出一种IVS2 + G62T序列变异,但在肥胖受试者和对照者中的患病率相似。IVS2 + G62T多态性的G等位基因纯合子(GG)的肥胖女性受试者血糖最高(N = 56;P = 0.033),该样本中的所有糖尿病患者(n = 6)均在该组中。IVS2 + G62T多态性也与BMI(P = 0.014)、舒张压(P = 0.009)和矢状径(P = 0.032)相关。第111密码子处的错义点突变(Tyr111His)与任何肥胖相关表型均无关联。总之,脂联素DNA序列变异可能在病态肥胖的并发症中起作用,应进一步研究。